-
841por Di Spirito, Federica, Amato, Alessandra, Di Palo, Maria Pia, Contaldo, Maria, D’Ambrosio, Francesco, Lo Giudice, Roberto, Amato, Massimo“…Nine cases were diagnosed following Pfizer-BioNTech, two Moderna, and one AstraZeneca, Serum Institute of India, Sinopharm, and Johnson&Johnson vaccines, respectively; specifically, eight after the first dose and seven after the second. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
842“…We report a case of a previously healthy, young male who had a cardiopulmonary arrest 2 min after receiving the Oxford- AstraZeneca (ChAdOx1 nCoV-19) COVID-19 vaccination. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
843por Mucci, A., Galderisi, S., Rocca, P., Rossi, A., Bertolino, A., Rucci, P., Maj, M.“…DISCLOSURE: Honoraria, advisory board, or consulting fees from Angelini, Astra Zeneca, Bristol-Myers Squibb, Gedeon Richter Bulgaria, Innova-Pharma, Janssen Pharmaceuticals, Lundbeck, Otsuka, Pfizer, and Pierre Fabre, for services not related to this abstract…”
Publicado 2022
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
844por Baqi, Dana H., Kakamad, Fahmi H., Mahmood, Zana H., Fattah, Fattah H., Ahmed, Shaho F., Hassan, Marwan N., Hama Amin, Bnar J., Mohammed, Shvan H., Mikael, Tomas M., Hassan, Hunar A., Salh, Abdulwahid M.“…The mean time from the administration of the vaccine to the onset of symptoms was 2 days (0–10 days). The AstraZeneca vaccine was responsible for more than half of the reported events. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
845“…As a result, ‘Oxford-AstraZeneca’ vaccine was the least appreciated among people. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
846“…Results: During this period, ocular adverse effects have been reported with BNT162b2 (Pfizer), mRNA-1273 (Moderna), AZD-1222 (AstraZeneca), and Ad26.COV2.S (Johnson & Johnson) vaccines. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
847por Genco, Lucia, Cantelli, Mariateresa, Noto, Matteo, Battista, Teresa, Patrì, Angela, Fabbrocini, Gabriella, Vastarella, Maria“…Various skin diseases have already been reported because of the vaccines (the Pfizer-BioNTech COVID-19 vaccine, the Moderna COVID-19 vaccine, the AstraZeneca vaccine) against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
848por Hafsteinsdóttir, Brynhildur, Dalemo, Ellen, Elíasdóttir, Ólöf, Ólafsson, Elías, Axelsson, Markus“…Three cases were temporally associated with SARS-CoV-2 infection and 1 case each to the AstraZeneca and Pfizer-BioNTech COVID-19 vaccines. CONCLUSIONS: Our results show that the incidence of Guillain-Barré syndrome decreased during the pandemic. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
849“…By then, only three COVID-19 vaccines had received emergency use authorization in the country—the Janssen, AstraZeneca and Pfizer-BioNtech vaccines. It is worth noting that NRAs should only approve a vaccine if they are satisfied that its benefits outweigh any potential risks and not through political pressure. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
850por Madut, Deng B, Chemaly, Roy F, Dadwal, Sanjeet S, Hill, Joshua A, Lee, Yeon Joo, Haidar, Ghady, Luk, Alfred, Drelick, Alexander Christian, Chin-Hong, Peter V, Benamu, Esther, Khawaja, Fareed, Nanayakkara, Deepa D, Papanicolaou, Genovefa, Small, Catherine, Fung, Monica, Barron, Michelle, Davis, Thomas, McClain, Micah T, Maziarz, Eileen K, Bedoya, Armando, Gilstrap, Daniel, Todd, Jamie, Heldman, Madeleine R, Barkauskaus, Christina, Bigelow, Robert, Leimberger, Jeffrey, Tsalik, Ephraim, Wolf, Olivia, Mughar, Mona, Hollemon, Desiree, Duttagupta, Radha, Lupu, Daniel, Bercovici, Sivan, Perkins, Bradley A, Blauwkamp, Timothy A, Fowler, Vance G, Holland, Thomas L, Bergin, Stephen P“…Fowler, MD, MHS, Amphliphi Biosciences, Integrated Biotherapeutics; C3J, Armata, Valanbio; Akagera, Aridis, Roche, Astra Zeneca: Advisor/Consultant|Genentech, Regeneron, Deep Blue, Basilea, Janssen;: Grant/Research Support|Infectious Diseases Society of America: Honoraria|MedImmune, Allergan, Pfizer, Advanced Liquid Logics, Theravance, Novartis, Merck; Medical Biosurfaces; Locus; Affinergy; Contrafect; Karius;: Grant/Research Support|Novartis, Debiopharm, Genentech, Achaogen, Affinium, Medicines Co., MedImmune, Bayer, Basilea, Affinergy, Janssen, Contrafect, Regeneron, Destiny,: Advisor/Consultant|Sepsis diagnostic: Patent pending|UpToDate: Royalties|Valanbio and ArcBio: Stock Options Thomas L. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
851por Bagacean, Cristina, Letestu, Rémi, Al Nawakil, Chadi, Brichler, Ségolène, Lévy, Vincent, Sritharan, Nanthara, Delmer, Alain, Dartigeas, Caroline, Leblond, Véronique, Roos-Weil, Damien, Béné, Marie C, Clavert, Aline, Chaoui, Driss, Genet, Philippe, Guieze, Romain, Laribi, Kamel, Touileb, Yamina, Drenou, Bernard, Willems, Lise, Tomowiak, Cécile, Merabet, Fatiha, Puppink, Christian, Legendre, Hugo, Troussard, Xavier, Malartre, Stéphanie, Cymbalista, Florence, Michallet, Anne-Sophie“…Laribi: Astellas Phama, Inc.: Other: Personal Fees; BeiGene: Other: Personal Fees; AstraZeneca: Other: Personal Fees; IQONE: Other: Personal Fees; AbbVie: Other: Personal Fees, Research Funding; Takeda: Other: Personal Fees, Research Funding; Novartis: Other: Personal Fees, Research Funding; Le Mans Hospital: Research Funding; Jansen: Research Funding. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
852por Svoboda, Jakub, Ballard, Hatcher J, Ho, Carrie I, Hughes, Mitchell E., Chong, Elise A, Duca, Adam, Prischak, Sara, Dwivedy Nasta, Sunita, Ruella, Marco, Landsburg, Daniel J, Barta, Stefan K., Gerson, James N, Schuster, Stephen J.“…DISCLOSURES: Svoboda: Incyte: Research Funding; Genmab: Consultancy; Merck: Research Funding; Pharmacyclics: Consultancy, Research Funding; BMS: Consultancy, Research Funding; TG: Research Funding; Imbrium: Consultancy; Seattle Genetics: Consultancy, Research Funding; Astra Zeneca: Consultancy, Research Funding; Atara: Consultancy; Adaptive: Consultancy, Research Funding. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
853“…We also show that delaying the delivery of the 2(nd) dose of the Astra Zeneca vaccine, as proposed by the Government of India, would have had only slightly more deleterious impacts, supporting the government’s decision to vaccinate a greater fraction of the population with at least a single dose as rapidly as possible. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
854por Odeigah, Louis Okeibunor, Mutalub, Yahkub Babatunde, Agede, Olalekan Ayodele, Obalowu, Ismail A., Aiyetoro, Susan, Jimoh, Gafar A. A.“…A retrospective descriptive study of the adverse events following AstraZeneca COVID-19 vaccination that were reported from five immunization centers of Kwara State, North-central Nigeria from March to July 2021 was carried out. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
855por Nunez, Freddy A., Castro, Ana C. H., Daher, Isabela P., Cunha-Neto, Edecio, Kalil, Jorge, Boscardin, Silvia B., Lanfredi, Alexandre J. C., de Oliveira, Vivian L., Alves, Wendel A.“…We successfully assessed its applicability using serum samples from spike-based COVID-19 vaccines: ChAdOx1-S (Oxford–AstraZeneca) and BNT162b2 (Pfizer–BioNTech). Overall, the ZnONRs/ spike-modified electrode displayed accurate results for both vaccines, showing excellent potential as a tool for assessing and monitoring seroprevalence in the population. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
856“…This study analyzes Twitter posts about Pfizer/BioNTech, Moderna, AstraZeneca/Vaxzevria, and Johnson & Johnson vaccines by considering the most spoken western languages. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
857“…We report a woman who developed reddish, partially urticarial skin lesions on her right arm and flank shortly after the first dose with the corona vaccination from AstraZeneca/Oxford (ChAdOx1). The lesions were transient, however reoccurred in loco and at other locations over several days. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
858“…Thirteen studies reported using BNT162b2 (Pfizer-BioNTech, USA), four reported using ChAdOx-nCov19 (AstraZeneca, U.K), two were reported using CoronaVac (Sinovac, China), and two were reported using mRNA1273 (Moderna, USA). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
859por Pavlidis, George, Giannoulis, Vasileios, Pirounaki, Maria, Lampropoulos, Ioannis C., Siafi, Eirini, Nitsa, Alkippi, Pavlou, Efthymia, Xanthaki, Anna, Perlepe, Garyfallia, Fortis, Sotirios P., Charalambous, George, Kampolis, Christos F., Pantazopoulos, Ioannis“…Eight hundred and three subjects were included, of whom 758 (94.4%) received the BNT162b2 vaccine (Pfizer-BioNTech), eight (1%) mRNA-1273 (Moderna), 14 (1.7%) ChAdOx1 (Oxford-AstraZeneca) and 23 (2.9%) Ad26.COV2.S (Janssen). Before the second dose, at 2, 6 and 9 months after the second dose and at 2 and 6 months after the third dose, anti-spike IgG were quantified by the chemiluminescence microparticle immunoassay method. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
860“…Herein, we report a case of severe optic neuritis developed shortly after AstraZeneca COVID-19 vaccination in an allogeneic HSCT recipient with underlying chronic GVHD. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto